Discovery explains why influenza B virus exclusively infects humans; opens door for drug development

August 25, 2011
Three-dimensional structure of a complex between influenza B virus protein, NS1B, is represented as the solid form, and the human protein that fights infections, ISG15, is represented as pink and magenta ribbons and strands. The sequence of the ISG15 protein found only in humans and non-human primates, represented as a short dark blue strand, binds to the NS1B protein, immobilizing ISG15 and preventing it from fighting the virus. Researchers determined the structure using X-ray crystallography. Credit: Rongjin Guan, et. al., Rutgers and University of Texas at Austin

Researchers at Rutgers University and the University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight seasonal influenza epidemics caused by the common influenza B strain.

Their discovery also helps explain how influenza B is limited to humans, and why it cannot be as virulent as A strains that incorporate new genes from that infect other species. The devastating flu pandemic of 1918, the pandemics of 1968 and 1977, and the that emerged in the middle of the last decade were caused by influenza A viruses. Understanding features of influenza B virus that limit it to humans will help scientists better understand how influenza A strains are able to cross species.

The researchers have determined the three-dimensional structure of a complex between an influenza B and one of its targets, resulting in suppression of the cell's natural defenses to the infection and paving the way for the virus to replicate efficiently.

Their findings are detailed in a paper published in the most recent issue of PNAS ().

"Our study shows the basis by which non-structural protein 1 of influenza B, or NS1B, binds to a human , immobilizing it to prevent it from fighting the virus," said Gaetano Montelione, a lead author and professor of biochemistry and molecular biology, School of Arts and Sciences, at Rutgers. That human protein, known as interferon-stimulated gene 15 protein or ISG15, is an essential part of the defense mechanism that use to protect themselves from viral infections. Chemicals that block the binding of NS1B to ISG15 may have antiviral potential against influenza B virus.

The study, led by professors Montelione and Robert Krug at the University of Texas at Austin, also reveals why NS1B cannot bind ISG15 molecules in other species, such as dogs or mice. Only human and non-human primate ISG15 proteins have a unique molecular sequence in a small part of the protein that makes it possible to bind to the NS1B protein. So far, influenza B virus has been found only in humans.

"The three-dimensional structure of the NS1B-ISG15 complex, which we determined using X-ray crystallography, has given us a clear understanding of the molecular basis for this species specificity," said Krug, professor and chair of molecular genetics and microbiology.

"Flu infections continue to be a major health problem, with more effective drugs critically needed to treat infected individuals and control potential pandemics," said Aaron Shatkin, director of the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers and an eminent virologist. "This discovery opens new possibilities for achieving these very important goals."

Related Stories

Recommended for you

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.